AlphaYouNWCL: de Bourdoncle de Saint Salvy Anne-Francois discloses securities transactions
By AlphaYouPublished Form 4
de Bourdoncle de Saint Salvy Anne-Francois
Reporting filer
de Bourdoncle de Saint Salvy Anne-Francois reported Grant or award in newcleo plc: 3432 units of Stock Options (Right to Buy) (derivative), dated 2026-09-21. The full Form 4 contains 1 transaction entry.
- Disclosed
- Sep 24, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) (derivative) | de Bourdoncle de Saint Salvy Anne-Francois | 2026-09-21 | A | Grant or award | 3432 | 0 | 37,766 | 3 days | Filed terms
|
Stock Options (Right to Buy) (derivative)
- Owner
- de Bourdoncle de Saint Salvy Anne-Francois
- Date
- 2026-09-21
- Code
- A
- Action
- Grant or award
- Quantity
- 3432
- Price
- 0
- Following holdings
- 37,766
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Stock Options (Right to Buy)
- id: F1
- conversion Or Exercise Price: 0.0228
- transaction Date: 2026-09-21
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 3432
- id: F1
- id: F2
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- id: F2
- expiration Date: 2035-06-17
- underlying Security Title: Ordinary Shares
- underlying Security Shares: 3432
- shares Owned Following Transaction: 37766
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- de Bourdoncle de Saint Salvy Anne-Francois: Director.
- F1: Reflects the grant of "Company Earnout Bonus Options" to purchase Ordinary Shares in accordance with that certain Business Combination Agreement, dated as of May 26, 2026, by and between Newhold Investment Corp III, Newcleo1 Ltd., Newcleo2 Ltd., and Newcleo Ltd. (the "BCA"). In accordance with the BCA, the Company Earnout Bonus Options will vest and become exercisable as follows: (i) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading days within a 30 trading day period, provided that such price attainment occurs during the period beginning on September 21, 2026 and ending on the five-year anniversary thereof.
- F2: The Company Earnout Bonus Options are fully vested as to service.
Original sources
Prepared automatically from public filing data. Report a correction.